Patients with chronic respiratory failure who meet usage criteria will have more access to respiratory assist devices.

The study followed 351 patients across four Korean hospitals who had received anti-tuberculosis treatment for more than six months. These individuals were monitored over 11 years (132 months) to ...

Chronic obstructive pulmonary disease (COPD) affects 25 million people in the U.S. and is the fifth leading cause of death ...

Women aged 40 years and older have a 50% greater risk for chronic obstructive pulmonary disease (COPD) vs men in the same age group, according to study findings published in BMJ Open Respiratory ...

Researchers looked at lung tissue from 28 COPD patients and 15 smokers who underwent surgery for suspected or confirmed lung ...

COPD has a large economic impact on the healthcare system and a destructive impact on the lives of patients and their ...

Regardless of chronic obstructive pulmonary disease status, finerenone mitigates clinical events and symptoms in patients with HFmrEF or HFpEF.

The QoL ratings were similar across ages in individuals on non-invasive support for chronic respiratory failure, though flare ...

Investigators concluded that individuals with comorbidities experienced higher risks of severe COVID-19 outcomes during the ...

According to a new comprehensive report from The Insight Partners, the global pulmonary drug delivery system market is ...